CRYOLIFE INC (CRY) Stock Price & Overview

NYSE:CRY

Current stock price

17.88
+0.25 (+1.42%)
At close:
17.88
0 (0%)
After Hours:

The current stock price of CRY is 17.88 null. Today CRY is up by 1.42%. In the past month the price decreased by -10.29%. In the past year, price decreased by -29.19%.

CRY Key Statistics

52-Week Range16.95 - 32.34
Current CRY stock price positioned within its 52-week range.
1-Month Range17.49 - 22.005
Current CRY stock price positioned within its 1-month range.
Market Cap
703.22M
P/E
59.60
Fwd P/E
265.53
EPS (TTM)
0.30
Dividend Yield
N/A

CRY Stock Performance

Today
+1.42%
1 Week
-4.08%
1 Month
-10.29%
3 Months
-15.02%
Longer-term
6 Months -30.59%
1 Year -29.19%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CRY Stock Chart

CRYOLIFE INC / CRY Daily stock chart

CRY Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CRY. When comparing the yearly performance of all stocks, CRY is a bad performer in the overall market: 78.27% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CRY Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CRY. While CRY is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRY Earnings

Next Earnings DateFeb 10, 2022
Last Earnings DateN/A
PeriodQ3 / 2021
EPS Reported-$0.05
Revenue Reported
EPS Surprise -147.52%
Revenue Surprise -1.26%

CRY Forecast & Estimates

8 analysts have analysed CRY and the average price target is 33.09 null. This implies a price increase of 85.05% is expected in the next year compared to the current price of 17.88.

For the next year, analysts expect an EPS growth of -91.22% and a revenue growth 18.02% for CRY


Analysts
Analysts82.5
Price Target33.09 (85.07%)
EPS Next Y-91.22%
Revenue Next Year18.02%

CRY Groups

Sector & Classification

Index Membership

CRY Financial Highlights

Over the last trailing twelve months CRY reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 130.77% compared to the year before.


Income Statements
Revenue(TTM)358.43M
Net Income(TTM)-1.33M
Industry RankSector Rank
PM (TTM) -0.37%
ROA -0.16%
ROE N/A
Debt/Equity 1
Chartmill High Growth Momentum
EPS Q2Q%-138.46%
Sales Q2Q%10.87%
EPS 1Y (TTM)130.77%
Revenue 1Y (TTM)40.55%

CRY Ownership

Ownership
Inst Owners91.55%
Shares39.33M
Float37.61M
Ins Owners5.73%
Short Float %N/A
Short RatioN/A

About CRY

Company Profile

CRY logo image CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. The company is headquartered in Kennesaw, Georgia and currently employs 1,200 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The firm operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.

Company Info

IPO: 1993-02-12

CRYOLIFE INC

1655 Roberts Blvd NW

Kennesaw GEORGIA 30144 US

CEO: J. Patrick Mackin

Employees: 1200

CRY Company Website

Phone: 17704193355.0

CRYOLIFE INC / CRY FAQ

What does CRY do?

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. The company is headquartered in Kennesaw, Georgia and currently employs 1,200 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The firm operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.


What is the stock price of CRYOLIFE INC today?

The current stock price of CRY is 17.88 null. The price increased by 1.42% in the last trading session.


Does CRY stock pay dividends?

CRY does not pay a dividend.


What is the ChartMill technical and fundamental rating of CRY stock?

CRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the sector and industry classification for CRYOLIFE INC?

CRYOLIFE INC (CRY) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Is CRYOLIFE INC (CRY) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CRY.


Can you provide the market cap for CRYOLIFE INC?

CRYOLIFE INC (CRY) has a market capitalization of 703.22M null. This makes CRY a Small Cap stock.